Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

The dog's condition improved after 21 days of treatment.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Facial trichostasis spinulosa is a chronic condition with significant cosmetic impact, especially in young women.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Rituximab may cause skin issues, but baricitinib can help improve them.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

Transfersomes are better than liposomes for targeting hair follicles in alopecia treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Steroid pulse therapy improved symptoms in a man with Satoyoshi syndrome.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.